Nomura Securities on Universal Banks: BofA (BAC) Vs. Citi (C)
Get Alerts BAC Hot Sheet
Price: $56.00 -0.36%
Rating Summary:
26 Buy, 18 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Rating Summary:
26 Buy, 18 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Join SI Premium – FREE
Nomura Securities on Universal Banks by Glenn Schorr
Schorr said, "A valuation comparison between BofA (NYSE: BAC) and Citi (NYSE: C), where C has the edge, in our view. Citi’s and BAC’s stocks are down ~36% and 43%, respectively, since the beginning of July (versus down ~13% for the S&P 500) and are now trading on a similar price to tangible book (C - 55%, BAC - 50%). We think the sell-off in both stocks may be overdone, particularly for Citi because, relative to BAC, the firm’s risk profile is materially different (less mortgage-related tail risk, higher capital/reserves, less legal/regulatory pressures), and Citi has greater exposure to the higher-growth markets in Asia and Latin America. We think Citi is the more attractive opportunity compared to BAC."
Schorr said, "A valuation comparison between BofA (NYSE: BAC) and Citi (NYSE: C), where C has the edge, in our view. Citi’s and BAC’s stocks are down ~36% and 43%, respectively, since the beginning of July (versus down ~13% for the S&P 500) and are now trading on a similar price to tangible book (C - 55%, BAC - 50%). We think the sell-off in both stocks may be overdone, particularly for Citi because, relative to BAC, the firm’s risk profile is materially different (less mortgage-related tail risk, higher capital/reserves, less legal/regulatory pressures), and Citi has greater exposure to the higher-growth markets in Asia and Latin America. We think Citi is the more attractive opportunity compared to BAC."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi initiates coverage of Maze Therapeutics with Buy rating
- UiPath Inc. (PATH) PT Lowered to $15 at UBS Following Investor Day
- Constellation Brands (STZ) PT Lowered to $145 at UBS on Softer Consumer Backdrop
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Citi, NomuraSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share